Findings from Sun et al suggest that the GLP-1/GLP-1R axis acts on ovarian granulosa cells by modifying the phosphorylation site of forkhead box protein O1 to promote their viability, thereby promoting oocyte maturation in PCOS
TUNEL-positive cells within TLS increased in the sulfasalazine-treated group, while the number of Ki67-positive cells remained unchanged (Figure 5, C and D)
Different bodies have different needs and differences in hormonal activity, as well as microbiome diversity
If both medications are used, the goal should be to balance benefits without increasing the risk of side effects
Think of it as upgrading both the construction crew and the supply chain at the same time
As a key trial evaluating the efficacy of tirzepatide, SURMOUNT-1 (NCT04184622) was consistent with the SURPASS studies in demonstrating dose-dependent weight loss [66]